Skip to main content
Premium Trial:

Request an Annual Quote

New French Proteomics Firm Launches

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Promise Advanced Proteomics, a French fee-for-service proteomics firm providing mass spectrometry-based absolute quantification services, has launched.

Based in Grenoble, France, Promise is a spinout of the Exploring the Dynamics of Proteomes laboratory at the National Institute of Health and Medical Research, the French Atomic Energy and Alternative Energies Commission, and Université Joseph Fourier. The company officially launched late last month, said Virginie Brun, the company's co-founder and chief scientific officer who was part of a team that developed the company's technology.

Promise provides services for the development of therapeutic proteins and biomarkers. Specifically, it employs a technology called Protein Standard Absolute Quantification for developing full-length isotopically-labeled proteins. The proteins can be used for quantitative proteomics and analytical research.

The technology was developed by researchers at the Exploring the Dynamics of Proteomes laboratory and was described in a 2007 interview with Brun by GenomeWeb Daily News' sister publication ProteoMonitor.

Promise holds an exclusive license to use the PSAQ technology, Brun said.

Nicolas Mouz is Promise's president and CEO.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more